|
|
|
| Analysis of Lys847del Mutation Site of MYH7 Gene in Chinese Han Families with Familial Hypertrophic Cardiomyopathy |
| HE Ping-ping, ZHANG Yu-qing, YANG Jun-hua, et al |
| Jiangning Hospital of Nanjing City , Nanjing, Jiangsu ,211100, China |
|
|
|
|
Abstract 【Objective】 To investigate the mutation site of the main pathogenic gene MYH7(beta-myosin heavy chain gene) in Chinese Han family with familial hypertrophic cardiomyopathy (HCM), and to analyze the correlation between their genotype and clinical phenotype. 【Methods】 A total of 9 families suffering from HCM were chosen for the study. The exons in the functional regions of the beta myosin heavy chain gene were amplified with PCR and the products were sequenced, including TNNT2,MYBPC3,MYH7,TNNI3.The identified mutations were further detected through bidirectional Sanger sequencing in all family members and 60 healthy volunteers. Pedigree analysis included physical examination, clinical symptoms, electrocardiography (ECG), echocardiography(UCG) and 3.0T cardiac magnetic resonance (CMR), and regular outpatient visits or telephone follow-up. 【Results】 The Lys847del mutation in exon 22 of beta-myosin heavy chain gene was found in one family. However, no abnormality was observed in the same position in all healthy volunteers In this family, beside the proband showed Lys847del mutation, his mother and his daughter carried the same mutation of exon 22 in MYH7 gene. The mother of the proband was diagnosed as HCM following family screening and daughter did not meet the diagnostic criteria for HCM. 【Conclusion】 The Lys847del mutation in exon 22 of MYH7 may be the pathogenic mutation gene of familial HCM in China. Patients with hypertrophic cardiomyopathy with this mutant genotype may present a similar clinical phenotype.
|
|
Received: 18 January 2018
|
|
|
|
|
|
[1] Maron MS, Rowin EJ, Olivotto I,et al.Contemporary natural history and management of nonobstructive hypertrophic cardiomyopathy[J].Am Coll Cardiol,2016, 67(12):1399-1409.
[2] 王博,郭瑞琦,左蕾,等.肥厚型心肌病家系MYH7-V878A突变与临床表型的关系[J].中华医学遗传学杂志,2017,34(4):514-518.
[3] Tanjore R, RangaRaju A, Vadapalli S, et al. Genetic variations ofβ-MYH7 in hypertrophic cardiomyopathy and dilated cardiomyopathy[J].Indian J Hun Genet,2010,16(3):67-71.
[4] Maron BJ, Maron MS.Hypertrophic cardiomyopathy[J].Lancet,2013, 381(9862):242-255.
[5] 曹红,赵跃,冯悦,等.中国人群肥厚型心肌病基因突变的研究与展望[J].医学分子生物学杂志, 2016, 13(1):27-34.
[6] 刘杰,刘文玲,胡大一,等.中国大样本队列肥厚型心肌病患者基因突变谱及临床相关性[J].中华心血管病杂志,2015, 43(8):684-689.
[7] 代凤丹,杨大春.基因突变在肥厚型心肌病发病中作用的研究进展[J].西南军医,2017, 19(2):180-183.
[8] Witjas-Paalberends ER,Piroddi N,Stam K,et al.Mutations in MYH7 reduce the force generating capacity of sarcomeres inhuman familial hypertrophic cardiomyopathy[J].Cardiovasc Res,2013,99(3):432-441.
[9] 崔宏丽,王东,冯新星,等.肥厚型心肌病致病基因型与临床表现的关系及基因筛查在肥厚型心肌病筛查及疾病鉴别诊断中的作用[J].中国循环杂志. 2015, 30(2):149-153.
[10] Maron BJ.Hypertrophic cardiomyopathy:a systematic review [J].JAMA,2002, 287(10):1308-1320. |
|
|
|
2018, Vol. 35 
